Pemphigoid diseases

E Schmidt, D Zillikens - The Lancet, 2013 - thelancet.com
Pemphigoid diseases are a group of well defined autoimmune disorders that are
characterised by autoantibodies against structural proteins of the dermal–epidermal junction …

Bullous pemphigoid: a review of its diagnosis, associations and treatment

P Bernard, F Antonicelli - American journal of clinical dermatology, 2017 - Springer
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease
in Western countries, and typically affects the elderly. BP is immunologically characterized …

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

L Borradori, N Van Beek, C Feliciani… - Journal of the …, 2022 - Wiley Online Library
Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
blistering disease of the skin and mucous membranes. This disease typically affects the …

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology …

E Schmidt, H Rashid, AV Marzano… - Journal of the …, 2021 - Wiley Online Library
This guideline has been initiated by the task force Autoimmune Blistering Diseases of the
European Academy of Dermatology and Venereology, including physicians from all relevant …

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

C Feliciani, P Joly, MF Jonkman… - British journal of …, 2015 - academic.oup.com
Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of
the skin and mucous membranes. This disease typically affects the elderly and presents with …

[HTML][HTML] Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid

K Izumi, W Nishie, Y Mai, M Wada, K Natsuga… - Journal of investigative …, 2016 - Elsevier
Bullous pemphigoid (BP) is a major autoimmune blistering skin disorder, in which a majority
of the autoantibodies (autoAbs) target the juxtamembranous extracellular noncollagenous …

Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management

KT Amber, DF Murrell, E Schmidt, P Joly… - Clinical reviews in allergy …, 2018 - Springer
Autoimmune subepidermal blistering diseases of the skin and mucosae constitute a large
group of sometimes devastating diseases, encompassing bullous pemphigoid, gestational …

Bullous pemphigoid: trigger and predisposing factors

F Moro, L Fania, JLM Sinagra, A Salemme, G Di Zenzo - Biomolecules, 2020 - mdpi.com
Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal blistering disease
provoked by autoantibodies directed against two hemidesmosomal proteins: BP180 and …

Efficacy and safety of dupilumab in moderate-to-severe bullous pemphigoid

Y Zhang, Q Xu, L Chen, J Chen, J Zhang… - Frontiers in …, 2021 - frontiersin.org
Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that
predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are …

Bullous pemphigoid

IS Bağcı, ON Horváth, T Ruzicka, M Sárdy - Autoimmunity reviews, 2017 - Elsevier
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …